期刊文献+

丹参酮脂质传递体的制备及体外经皮渗透研究 被引量:18

Preparation and transdermal resorption of tanshinone ethosomes in vitro
在线阅读 下载PDF
导出
摘要 目的研制丹参酮脂质传递体,进行体外小鼠经皮渗透研究。方法采用薄膜超声法制备脂质传递体。以改进的Franz扩散池进行体外经皮渗透实验,比较不同给药形式和给药体积对丹参酮经皮渗透的影响。结果脂质传递体粒径79.7nm,包封率达81.2。脂质传递体12h累积透过量为(1024±104.0)ng/cm2,皮肤滞留量为(345.2±58.0)ng/cm2;普通脂质体12h内接收介质中未检测到药物,皮肤滞留量为(625.3±124.5)ng/cm2,水醇混悬液仅在给药8h后才检测到少量药物,皮肤滞留量为(765.0±60.00)ng/cm2,随脂质传递体给药体积增大(0.1,0.2,0.5mL),12h皮肤累积透过量提高(依次为676.4±63.69、1024±104.0、1410±77.20ng/cm2),透皮速率增加(分别为63.78±7.79、97.27±9.14、140.0±5.50ng(cm2·h)),皮肤滞留量增加(依次为64.70±7.50、345.2±58.0、628.3±98.11ng/cm2)。结论脂质传递体可以促进丹参酮经皮转运。 AIM : To prepare ethosomes and study on transdermal resorption of tanshinone ethosomes in vitro. METHODS: Tanshinone ethosomes were prepared by thin-film ultrasonic method. The different dosage regimens and volume on the transdermal resorption of tanshinone were evaluated through excised mice skin in vitro using modified Franz-diffustion cells. RESULTS : The mean particle diameter of ethosomes was 79.7 nm, and the encapsulation efficiency was about 81.2%. Cumulative penetration amount of tanshinone from ethosomes was 1024 ± 104.0 ng/cm^2 and skin residual amount was 345.2 ± 58.0 ng/cm^2. Cumulative penetration amount increased with ethosomes volume. Liposomes failed to promote the penetration of tanshinone, and its skin residual amount was 625.3 ±124.5 ng/cm^2, water-ethanolic suspension also could not promote the penetration of tanshinone, and skin residual amount was 765.0 ± 60.00 ng/cm^2. CONCLUSION:Ethosomes can improve significantly the transdermal delivery of tanshinone.
出处 《中成药》 CAS CSCD 北大核心 2005年第9期1000-1003,共4页 Chinese Traditional Patent Medicine
基金 江苏省科委高新技术招标项目(BG2002023)
关键词 丹参酮 丹参酮ⅡA 脂质传递体 透皮吸收 体外 tanshinone tanshinone Ⅱ A ethosomes transdermal resorption in vitro
  • 相关文献

参考文献8

  • 1Touitou E, Dayan N, Bergelson L,et al. Ethosomess-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties [ J ]. J Controlled Release, 2000,65:403-418.
  • 2Cevc G, Schatzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double lable CLSM experiments and di rect size measurements[ J]. Biochem Biophys Acta ,2002,1564:21 -30.
  • 3Cevc G, Gebauer D. Hydration-driven transport of deformable lip id vesicles through fine pores and the skin barrier[ J]. Biophys J, 2003,84 : 1010-1024.
  • 4陈文浩,刘玉玲.含醇脂质体ethosomes的特性、透皮机制及应用[J].中国药学杂志,2003,38(7):490-493. 被引量:7
  • 5Touitou E, Godin B. Enhanced delivery of drugs into and acrossthe skin by ethosomal carriers [ J ]. Drug Dev Res, 2000,50: 406- 415.
  • 6Eouitou. Composition for applying active substances to or through the skin[ P] ,USP 5716638. 1998.
  • 7刘建平,娄莉华,吴崎.促进剂对咳喘涂膜剂中黄芩苷经皮渗透的影响[J].中国药学杂志,1997,32(10):598-600. 被引量:8
  • 8Hu X, Liu Y, Lu J H,et al. Promoting effect of the ultradeformable liposomess on Transdermal Delivery [ J ]. J Chinese Pharm Sci, 2002,11 ( 1 ) :34-37.

二级参考文献7

共引文献13

同被引文献210

引证文献18

二级引证文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部